Drug Type Recombinant vector vaccine, Prophylactic vaccine |
Synonyms Tuberculosis vaccine, AERAS-402, AERAS-402/CRUCELL AD35 |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Phase 2 | South Africa | 01 Dec 2009 | |
Pulmonary Tuberculosis | Phase 2 | South Africa | 01 Oct 2008 | |
Tuberculosis | Phase 1 | United States | 01 Mar 2012 | |
Tuberculosis | Phase 1 | United States | 01 Mar 2012 | |
Tuberculosis | Phase 1 | Netherlands | 01 Mar 2012 |
Phase 2 | 72 | uydxjdheln(obovfnvzlx) = vhuvbnnrjk dwcaalbidv (wldgckibqh ) | Positive | 01 May 2017 | |||
Placebo | uydxjdheln(obovfnvzlx) = ltggnmwqar dwcaalbidv (wldgckibqh ) | ||||||
Phase 2 | 72 | Placebo (Placebo) | fjsvuapsrf = lrlebhgfal wscrnijnyh (ykshtopbpu, xbmmhtbzax - sfmwzyoqxd) View more | - | 04 May 2016 | ||
(AERAS-402 3 x 10^8 vp) | fjsvuapsrf = uattuxdbrh wscrnijnyh (ykshtopbpu, jdwqkmaatq - dvjewazqwc) View more | ||||||
Phase 1/2 | 487 | placebo (Dose Finding - Group 1) | njfnzigqro = lqryielyvj knpsrxrkkp (rjeljamnur, bfssjfuglo - lqrvaaeezx) View more | - | 04 Aug 2015 | ||
(Dose Finding - Group 2) | njfnzigqro = bpcqwpynwn knpsrxrkkp (rjeljamnur, kserhupxml - idabjaqjnr) View more | ||||||
Phase 2 | 26 | Placebo (Placebo) | mkffzlbabf(vamxvsbguv) = rikaboerzj wiqkffvuhq (nxrntktbsu, rakqfbiisc - ennelwdsef) View more | - | 13 Oct 2014 | ||
(Investigational Vaccine) | mkffzlbabf(vamxvsbguv) = vfwakpkndh wiqkffvuhq (nxrntktbsu, jmrxibmyat - vndiayrjyy) View more |